Announcements Trials
Browse Landscape

Phase

Phase 2 40Phase 1 35Phase 1/2 21Phase NA 11Phase 3 4Phase EARLY_PHASE1 2Phase 4 1

Status

Completed 10Recruiting 8Terminated 6Unknown 5Not yet recruiting 5Active not recruiting 3Withdrawn 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 15Neoplasms 11Pancreatic Neoplasms 10Prostatic Neoplasms 7Glioma 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Sarcoma 4Polycystic Ovary Syndrome 4Colonic Neoplasms 4Obesity 3Neoplasm Metastasis 3Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Brain Neoplasms 3Pain, Postoperative 2Lymphoma 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Depression 2Cholangiocarcinoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2

Interventions

motexafin gadolinium 1Vincristine 1Rituximab 1Radiotherapy 1Procarbazine 1Nivolumab 1Methotrexate 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Lymphoma × Clear all
NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Presage Biosciences

Phase EARLY_PHASE1 Withdrawn
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Northwestern University

Phase EARLY_PHASE1 Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡